qiyin liu - Search Results

Year	Number of Results
1989	1
1994	1
2000	1
2001	1
2004	1
2006	2
2008	1
2010	2
2011	1
2013	2
2014	1
2015	1
2016	1
2017	1
2019	1
2020	4
2021	1
2022	3
2023	3
2024	4

1

A versatile economic strategy by HPLC-CAD for quantification of structurally diverse markers in quality control of Shengmai Formula from raw materials to preparations.

Liu L, Fan W, Zhang H, Fan L, Mei Y, Wang Z, Li L, Yang L, Wang Z. Liu L, et al. Phytomedicine. 2024 Apr 10;129:155625. doi: 10.1016/j.phymed.2024.155625. Online ahead of print. Phytomedicine. 2024. PMID: 38692077

2

Analysis of clinical evidence on traditional Chinese medicine for the treatment of diabetic nephropathy: a comprehensive review with evidence mapping.

Gao Y, Li Z, Wang Y, Zhang H, Huang K, Fu Y, Xu S, Li Q, Liu X, Zhang G. Gao Y, et al. Front Endocrinol (Lausanne). 2024 Mar 27;15:1324782. doi: 10.3389/fendo.2024.1324782. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38601203 Free PMC article. Review.

3

Integrative proteomics and metabolomics explore the effect and mechanism of Qiyin granules on improving nonalcoholic fatty liver disease.

Yan X, Liu H, Huang M, Zhang Y, Zeng B. Yan X, et al. Heliyon. 2024 Feb 24;10(5):e27075. doi: 10.1016/j.heliyon.2024.e27075. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38444462 Free PMC article.

Hepatic transcriptomics further indicated that Qiyin potentially confers protective effects against NAFLD by mediating liver inflammation and fibrosis through lumican (LUM) and decorin (DCN). In summation, our investigation provides compelling evidence affirming the therap …

Hepatic transcriptomics further indicated that Qiyin potentially confers protective effects against NAFLD by mediating liver inflamma …

4

Mechanism difference of ginseng medicines with different natures on hyperthyroidism.

Liu L, Han X, Shan G, Fu L, Dou D. Liu L, et al. J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117194. doi: 10.1016/j.jep.2023.117194. Epub 2023 Sep 22. J Ethnopharmacol. 2024. PMID: 37742875

5

Ultra-weak photon emission as a potential tool for evaluating the therapeutic effect of traditional Chinese medicine in patients with type 2 diabetes.

Yang M, Zhang Z, Fu J, Liu J, Pang J, Fan H, Yang Z, Zhang Y, Han J. Yang M, et al. Heliyon. 2023 Jul 12;9(7):e18055. doi: 10.1016/j.heliyon.2023.e18055. eCollection 2023 Jul. Heliyon. 2023. PMID: 37519692 Free PMC article.

6

Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review.

Hou Y, Wang G, Han S, Liu H, Jia X. Hou Y, et al. Medicine (Baltimore). 2023 Jun 2;102(22):e33729. doi: 10.1097/MD.0000000000033729. Medicine (Baltimore). 2023. PMID: 37266620 Free PMC article. Review.

7

Study on the differences of gut microbiota composition between phlegm-dampness syndrome and qi-yin deficiency syndrome in patients with metabolic syndrome.

Shang H, Zhang L, Xiao T, Zhang L, Ruan J, Zhang Q, Liu K, Yu Z, Ni Y, Wang B. Shang H, et al. Front Endocrinol (Lausanne). 2022 Nov 9;13:1063579. doi: 10.3389/fendo.2022.1063579. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36440222 Free PMC article.

8

Treatment of type 2 diabetes mellitus using the traditional Chinese medicine Jinlida as an add-on medication: A systematic review and meta-analysis of randomized controlled trials.

Zhao X, Liu L, Liu J. Zhao X, et al. Front Endocrinol (Lausanne). 2022 Oct 17;13:1018450. doi: 10.3389/fendo.2022.1018450. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36325446 Free PMC article.

9

Effect of Baihe Gujin decoction combined with Shengmai powder on the expression of IL-1β and IL-1Ra in peripheral blood CD14+ monocytes from patients with pulmonary tuberculosis.

Wang K, Li L, Wang Y, Fang G, Wei M, Ding H, Liu W, Huang Z. Wang K, et al. Cell Mol Biol (Noisy-le-grand). 2022 Feb 28;68(2):60-63. doi: 10.14715/cmb/2022.68.2.9. Cell Mol Biol (Noisy-le-grand). 2022. PMID: 35869725 Clinical Trial.

10

The Distribution Pattern of Traditional Chinese Medicine Syndromes in 549 Patients with Type 2 Diabetes.

Zhang GD, Liu XX, Liang JL, Hu QM. Zhang GD, et al. Diabetes Metab Syndr Obes. 2021 May 17;14:2209-2216. doi: 10.2147/DMSO.S295351. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 34040406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year